English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/212523
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows

AuthorsGonzalez-Nieto, D.; Fernández-Serra, Rocío; Pérez-Rigueiro, José; Panetsos, Fivos; Martínez-Murillo, Ricardo ; Guinea, Gustavo V.
Brain ischemi
Oxidative stress
Spreading depression
Drug delivery
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationCells 9(5): 1074 (2020)
AbstractIschemic stroke represents one of the most prevalent pathologies in humans and is a leading cause of death and disability. Anti-thrombolytic therapy with tissue plasminogen activator (t-PA) and surgical thrombectomy are the primary treatments to recanalize occluded vessels and normalize the blood flow in ischemic and peri-ischemic regions. A large majority of stroke patients are refractory to treatment or are not eligible due to the narrow time window of therapeutic efficacy. In recent decades, we have significantly increased our knowledge of the molecular and cellular mechanisms that inexorably lead to progressive damage in infarcted and peri-lesional brain areas. As a result, promising neuroprotective targets have been identified and exploited in several stroke models. However, these considerable advances have been unsuccessful in clinical contexts. This lack of clinical translatability and the emerging use of biomaterials in different biomedical disciplines have contributed to developing a new class of biomaterial-based systems for the better control of drug delivery in cerebral disorders. These systems are based on specific polymer formulations structured in nanoparticles and hydrogels that can be administered through different routes and, in general, bring the concentrations of drugs to therapeutic levels for prolonged times. In this review, we first provide the general context of the molecular and cellular mechanisms impaired by cerebral ischemia, highlighting the role of excitotoxicity, inflammation, oxidative stress, and depolarization waves as the main pathways and targets to promote neuroprotection avoiding neuronal dysfunction. In the second part, we discuss the versatile role played by distinct biomaterials and formats to support the sustained administration of particular compounds to neuroprotect the cerebral tissue at risk of damage.
Description© 2020 by the authors.
Publisher version (URL)https://doi.org/10.3390/cells9051074
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
Biomaterials_Gonzalez_Art2020.pdf2,29 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.